9I制作厂免费

9I制作厂免费 awards $500,000 to accelerate Mpox research and vaccine development

Published: 13 February 2025

Montreal, February 13, 2025 鈥 9I制作厂免费鈥檚 DNA to RNA Initiative (D2R) and 9I制作厂免费 Interdisciplinary Initiative in Infection and Immunity (MI4) have awarded $500,000 to fund five high-impact...

Call for Applications: D2R Award in Genomic Medicine and Indigenous Health

Published: 30 July 2025

To mark the 25th anniversary of G茅nome Qu茅bec, 9I制作厂免费鈥檚 DNA to RNA (D2R) Initiative is launching a special call for applications for the D2R Award in Genomic Medicine and Indigenous...

D2R awards $400K to translate RNA research into real-world solutions

Published: 25 June 2025

Montreal, June 25, 2025 鈥 The DNA to RNA Initiative (D2R) at 9I制作厂免费 has awarded $400,000 to four projects that aim to bring RNA-based innovations closer to clinical and commercial...

iPSC Seminars: Early Drug Discovery Unit (EDDU)

Thursday, October 2, 2025 11:00to12:00

THE NEURO'S EDDU iPSC SEMINAR SERIES聽 Modeling 伪-Synuclein Pathology Spreading in a 3D Human Midbrain-Striatal Assembloid/neuroCategory:聽Medicine Research Medicine and Health Sciences MNI

9I制作厂免费 Innovation Fund (MIF) information session (VIRTUAL)

Thursday, September 25, 2025 13:00to14:00

The next application window of the MIF will open on September 22, 2025. This聽virtual聽session aims to explain the MIF program to potential applicants, and to provide an overview of the application...

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

Published: 25 March 2025

Free, online training program strengthens training and brings specialized care to communities across Quebec...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Pages

Back to top